Abstract:Background: Very early-onset inflammatory bowel disease (VEO-IBD) occurs in young children and causes severe clinical manifestations which have poor responses to traditional IBD treatments. At present, there are no simple and reliable laboratory indicators for early screening VEO-IBD patients especially those who were caused by monogenic diseases. Methods: A retrospective analysis was performed in 73 patients with VEO-IBD admitted to our hospital in the past 5 years. Based on the next-generation sequencing results they were divided into monogenic IBD group (M-IBD) and non-monogenic IBD group (NM-IBD). Forty age-matched patients with allergic proctocolitis were the control group (food allergy, FA). Evaluating the clinical manifestations and the inflammatory factors in peripheral blood. The logistic regression analysis and receiver operating characteristic (ROC) curve analysis were used to find the screening factors and cut-off values of VEO-IBD as well as monogenic VEO-IBD, respectively. Findings: Among the 73 VEO-IBD patients, 44 cases were in the M-IBD group, 35 of whom carried IL-10RA mutations, and the most common mutations were c.301C>T (p.R101W, 30/70) and the c.537G>A (p.T179T, 17/70). The higher the serum TNF-α value was, the greater the risk of diagnosing IBD (OR=1·25, 95%CI: 1·05, 1·50, P=0·013) and the higher serum albumin level meant it was less likely to have IBD (OR= 0·86, 95%CI: 0·74, 1·00, P=0·048). ROC analysis showed that the cut-off values of TNF-α and albumin were 17·40 pg/mL ( sensitivity: 0·78, specificity: 0·88 ) and 36·50 g/L (sensitivity: 0·80, specificity: 0·90), respectively. The increased ferritin level was indicative of a genetic mutation in VEO-IBD patients. Its cut-off value was 28·20 ng/mL (sensitivity: 0·93, specificity: 0·92). Moreover, when IL-10 level was higher than 33·05 pg/ml (sensitivity: 1·00, specificity: 0·84), or the onset age was earlier than 0·21 months (sensitivity: 0·82, specificity: 0·94), it was strongly suggested the presence of disease-causing mutations in IL-10RA in VEO-IBD patients. Interpretation: A high proportion of Mendelian disease was present in VEO-IBD patients, of which IL-10RA was the most common disease-causing gene. Serum TNF-α and albumin level could be used for differentiating VEO-IBD patients from children with allergic proctocolitis, as well as serum ferritin and IL-10 may serve as early screening indicators for monogenic VEO-IBD, thereby shortening the time for disease diagnosis. Funding: This study was funded by Scientific researching fund of Shanghai Municipal Health Commission(No·201640368) and National Natural Science Foundation of China Grant (No·81741103).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: This study was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University, School of Medicine. All guardians of the enrolled pediatric patients who experienced the gene test signed an informed consent form.

Family reflections: research gives back childhood: a family's experience with very early onset inflammatory bowel disease

Very Early Onset Inflammatory Bowel Disease: Diagnostic and Therapeutic Challenges for Pediatric Gastroenterologists

Family reflections: inflammatory bowel disease and dandelions

Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study

Family reflections: navigating VEOIBD: a mother's perspective on pediatric Crohn's disease and research advocacy

An Eleven Months Old Infant with Very Early Onset Inflammatory Bowel Diseases (IBD): A Rare Case Report

Clinical Features of 55 Patients with Very Early Onset Inflammatory Bowel Disease

Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease

Considerations in Paediatric and Adolescent Inflammatory Bowel Disease

A Study on the Interleukin-10 Receptor Gene Mutations and Neonatal Very Early Onset Inflammatory Bowel Disease in 5 Infants

Importance of early detection of infantile inflammatory bowel disease with defective IL-10 pathway: A case report

Umbilical cord blood stem cell transplantation treatment for very early onset inflammatory bowel disease due to IL-10RA mutation: A case report and literature review

Phenotype and Management of Infantile-onset Inflammatory Bowel Disease

Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.

Family reflections: George Elliott: a first-person commentary on pediatric aplastic anemia research

Very Early-Onset IBD-Associated IL-18opathy Treated with an Anti-IL-18 Antibody

A Retrospective Study of 73 Chinese Children with Very Early Onset Inflammatory Bowel Disease (VEO-IBD): Searching for Laboratory Indicators for Early Screening of Patients with Monogenic VEO-IBD

Very-early-onset Inflammatory Bowel Disease in an Infant with a Partial RIPK1 Deletion

New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease

Understanding Endoscopic and Clinicopathological Features of Patients with Very Early Onset Inflammatory Bowel Disease: Results from a Decade of Study.

The intestinal microbiome of inflammatory bowel disease across the pediatric age range